Prostate cancer patients treated with gonadotrophin releasing hormone agonists (GnRH-a) have significantly lower bone mineral density (BMD) at almost all skeletal sites compared with both healthy ...
Prostate cancer patients treated with gonadotrophin releasing hormone agonists (GnRH-a) have significantly lower bone mineral density (BMD) at almost all skeletal sites compared with both healthy ...